+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

BioImaging Technologies - Global Strategic Business Report

  • PDF Icon

    Report

  • 174 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1946812
The global market for BioImaging Technologies is estimated at US$11.9 Billion in 2023 and is projected to reach US$31.6 Billion by 2030, growing at a CAGR of 15.0% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Several key factors drive the growth of bioimaging technologies. Advancements in AI and machine learning enable more sophisticated analysis, improving diagnostic accuracy and efficiency. Enhanced computational power and better algorithms allow for faster and more reliable image processing. The increasing demand for personalized medicine necessitates advanced imaging technologies to tailor therapies based on individual physiological and molecular profiles. Expanding biomedical research requires observing and analyzing biological processes at cellular and molecular levels, driving the need for advanced imaging tools. Rising healthcare expenditure, particularly in emerging economies, supports the adoption of bioimaging. Higher patient awareness and expectations for early and accurate diagnoses, along with supportive regulatory policies and cost reductions in imaging technology, further promote the widespread use of bioimaging systems in healthcare. These factors collectively underscore the significant role of bioimaging in modern medical and scientific domains.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Medical Technology segment, which is expected to reach US$19.5 Billion by 2030 with a CAGR of a 14.7%. The Molecular Technology segment is also set to grow at 15.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $3.3 Billion in 2023, and China, forecasted to grow at an impressive 14.2% CAGR to reach $4.8 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global BioImaging Technologies Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global BioImaging Technologies Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global BioImaging Technologies Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as BioClinica, Bracco Imaging SpA, Digirad Corporation, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 14 Featured):

  • BioClinica
  • Bracco Imaging SpA
  • Digirad Corporation
  • Esaote SpA
  • Fonar Corporation
  • FUJIFILM SonoSite, Inc.
  • GE Healthcare
  • Hitachi, Ltd.
  • Medtronic, Inc.
  • Philips Healthcare
  • Positron Corporation
  • Siemens Healthineers

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • BioImaging Technologies - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Demand for Advanced Diagnostic Imaging Techniques
  • Growth of Chronic Diseases and Aging Population
  • Advancements in Imaging Modalities and Technologies
  • Rising Adoption of Molecular Imaging and PET Scans
  • Impact of COVID-19 Pandemic on BioImaging Market
  • Government Regulations and Standards for Medical Imaging Devices
  • Expansion of BioImaging Applications in Drug Discovery and Development
  • Development of AI and Machine Learning in BioImaging Analysis
  • Consumer Preferences for Non-Invasive Diagnostic Procedures
  • Role of BioImaging in Personalized Medicine and Targeted Therapies
  • Market Penetration of BioImaging in Oncology and Neurology
  • Influence of Technological Innovations on BioImaging Accuracy and Speed
  • Growth of BioImaging in Academic and Research Institutions
  • Challenges Related to Data Management and Storage in BioImaging
  • Emerging Markets and Growth Opportunities in Developing Regions
  • Future Trends and Innovations in BioImaging Technologies and Applications
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for BioImaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for BioImaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for BioImaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Molecular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 16: World BioImaging Technologies Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 17: USA Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 18: USA Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 19: USA 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
  • Table 20: USA Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 21: USA Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: USA 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
CANADA
  • Table 23: Canada Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 24: Canada Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: Canada 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
  • Table 26: Canada Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: Canada Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: Canada 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
JAPAN
  • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 29: Japan Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: Japan Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: Japan 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
  • Table 32: Japan Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Japan Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: Japan 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
CHINA
  • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 35: China Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 36: China Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: China 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
  • Table 38: China Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: China Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: China 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
EUROPE
  • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 41: Europe Recent Past, Current & Future Analysis for BioImaging Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 42: Europe Historic Review for BioImaging Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: Europe 16-Year Perspective for BioImaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 44: Europe Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: Europe Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: Europe 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
  • Table 47: Europe Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 48: Europe Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: Europe 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
FRANCE
  • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 50: France Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: France Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: France 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
  • Table 53: France Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: France Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: France 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
GERMANY
  • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 56: Germany Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: Germany Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: Germany 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
  • Table 59: Germany Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: Germany Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: Germany 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
ITALY
  • Table 62: Italy Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: Italy Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: Italy 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
  • Table 65: Italy Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 66: Italy Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: Italy 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 68: UK Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: UK Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 70: UK 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
  • Table 71: UK Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 72: UK Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 73: UK 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 74: Rest of Europe Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: Rest of Europe Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 76: Rest of Europe 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
  • Table 77: Rest of Europe Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 78: Rest of Europe Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 79: Rest of Europe 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 80: Asia-Pacific Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: Asia-Pacific Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 82: Asia-Pacific 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
  • Table 83: Asia-Pacific Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 84: Asia-Pacific Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 85: Asia-Pacific 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
REST OF WORLD
  • Table 86: Rest of World Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Rest of World Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 88: Rest of World 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
  • Table 89: Rest of World Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 90: Rest of World Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 91: Rest of World 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BioClinica
  • Bracco Imaging SpA
  • Digirad Corporation
  • Esaote SpA
  • Fonar Corporation
  • FUJIFILM SonoSite, Inc.
  • GE Healthcare
  • Hitachi, Ltd.
  • Medtronic, Inc.
  • Philips Healthcare
  • Positron Corporation
  • Siemens Healthineers

Table Information